Hartford Investment Management CO Amgen Inc Transaction History

Hartford Investment Management CO

$2.99 Billion
Q3 2024

A detailed history of Hartford Investment Management CO transactions in Amgen Inc stock. As of the latest transaction made, Hartford Investment Management CO holds 33,805 shares of AMGN stock, worth $9.2 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

33,805

Previous 34,365 1.63%

Holding current value

$9.2 Million

Previous $10.7 Million 1.44%

% of portfolio

0.36%

Previous 0.37%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $173,252 - $188,932	-560 Reduced 1.63%	33,805 $10.9 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $52,024 - $63,223	-198 Reduced 0.57%	34,365 $10.7 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $401,691 - $484,892	-1,494 Reduced 4.14%	34,563 $9.83 Million
Q4 2023 Jan 23, 2024	SELL	$255.7 - $288.46 $212,742 - $239,998	-832 Reduced 2.26%	36,057 $10.4 Million
Q3 2023 Oct 16, 2023	SELL	$218.65 - $271.46 $224,553 - $278,789	-1,027 Reduced 2.71%	36,889 $9.91 Million
Q2 2023 Jul 19, 2023	SELL	$214.27 - $253.37 $1.6 Million - $1.9 Million	-7,484 Reduced 16.48%	37,916 $8.42 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $2.37 Million - $2.88 Million	-10,481 Reduced 18.76%	45,400 $11 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $83,137 - $105,636	-363 Reduced 0.65%	55,881 $14.7 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $188,321 - $212,392	839 Added 1.51%	56,244 $12.7 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $482,645 - $537,100	-2,092 Reduced 3.64%	55,405 $13.5 Million
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $854,933 - $945,780	-3,899 Reduced 6.35%	57,497 $13.9 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $826,147 - $945,450	4,154 Added 7.26%	61,396 $13.8 Million
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $1.59 Million - $1.87 Million	-7,505 Reduced 11.59%	57,242 $12.2 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $333,085 - $369,533	-1,426 Reduced 2.15%	64,747 $15.8 Million
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $551,224 - $642,362	-2,484 Reduced 3.62%	66,173 $16.5 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $1.51 Million - $1.8 Million	6,988 Added 11.33%	68,657 $15.8 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $617,129 - $686,298	-2,630 Reduced 4.09%	61,669 $15.7 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $1.94 Million - $2.39 Million	-9,831 Reduced 13.26%	64,299 $15.2 Million
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $75,447 - $100,063	414 Added 0.56%	74,130 $15 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $392,989 - $505,126	-2,077 Reduced 2.74%	73,716 $17.8 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $676,243 - $810,280	-3,884 Reduced 4.87%	75,793 $14.7 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $106,354 - $124,671	-638 Reduced 0.79%	79,677 $14.7 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $156,271 - $176,152	864 Added 1.09%	80,315 $15.3 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $123,452 - $144,109	-692 Reduced 0.86%	79,451 $15.5 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $605,157 - $682,234	-3,266 Reduced 3.92%	80,143 $16.6 Million
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $8.36 Million - $9.39 Million	-50,341 Reduced 37.64%	83,409 $15.4 Million
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $4.28 Million - $5 Million	-25,275 Reduced 15.89%	133,750 $22.8 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $862,010 - $963,129	-5,107 Reduced 3.11%	159,025 $27.7 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $27.5 Million - $31.3 Million	164,132	164,132 $30.6 Million

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Account

Hartford Investment Management CO Amgen Inc Transaction History